OpenAI has invested in Merge Labs’ seed round, backing the startup’s mission to bridge biological and artificial intelligence. Merge Labs is developing new brain-computer interfaces (BCIs) designed for higher bandwidth communication between humans and technology. The collaboration aims to make AI interaction more seamless and natural, leveraging AI to interpret neural signals and adapt to individual users.

The investment underscores a growing push into human-computer interaction. BCIs are seen as a frontier for enhancing communication, learning, and agency. OpenAI will collaborate on scientific foundation models and tools to accelerate Merge’s research in bioengineering and neuroscience. This move aligns with broader industry efforts to integrate AI with emerging hardware, moving beyond traditional screen-based interfaces.

Merge Labs’ co-founders include researchers Mikhail Shapiro, Tyson Aflalo, and Sumner Norman, alongside entrepreneurs Alex Blania, Sandro Herbig, and Sam Altman in a personal capacity. The partnership signals OpenAI’s strategic interest in foundational AI research that extends beyond software. Watch for developments in safe, high-bandwidth interfaces that could redefine how we interact with machines.